TEVA FY 2021 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$37B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$15.9B-4.7% YoY

Gross Profit

$7.6B47.8% margin

Operating Income

$1.7B10.8% margin

Net Income

$417M2.6% margin

EPS (Diluted)

$0.38

Cash Flow

Operating Cash Flow

$798M

Free Cash Flow

$236M

Stock-Based Comp.

$119M

Balance Sheet

Total Assets

$47.7B

Total Liabilities

$36.4B

Stockholders' Equity

$10.3B

Cash & Equivalents

$2.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15.9B	$16.7B	-4.7%
Gross Profit	$7.6B	$7.7B	-1.7%
Operating Income	$1.7B	-$3.6B	+148.0%
Net Income	$417M	-$4.0B	+110.5%